Abstract
Phyllanthus wightianus belongs to Euphorbiaceae family having ethnobotanical importance. The present study deals with validating the antimicrobial potential of solvent leaf extracts of P. wightianus. 11 human bacterial pathogens (Bacillus subtilis, Streptococcus pneumoniae, Staphylococcus epidermidis, Proteus vulgaris, Pseudomonas aeruginosa, Klebsiella pneumoniae, Salmonella typhimurium, Escherichia coli, Shigella flexneri, Proteus vulgaris, and Serratia marcescens) and 4 fungal pathogens (Candida albicans, Cryptococcus neoformans, Mucor racemosus, and Aspergillus niger) were also challenged with solvent leaf extracts usingagar well and disc diffusion methods. Further, identification of the active component present in the bioactive extract was done using GC-MS analysis. Results show that all extracts exhibited broad spectrum (6–29 mm) of antibacterial activity on most of the tested organisms. The results highlight the fact that the well in agar method was more effective than disc diffusion method. Significant antimicrobial activity was detected in methanol extract against S. pneumoniae (29 mm) with MIC and MBC values of 15.62 μg/mL. GC-MS analysis revealed that 29 bioactive constituents were present in methanolic extract of P. wightianus, of which 9,12-octadecaenioic acid (peak area 22.82%; RT-23.97) and N-hexadecanoic acid (peak area 21.55% RT-21.796) are the major compounds. The findings of this study show that P. wightianus extracts may be used as an anti-infective agent in folklore medicine.
1. Introduction
Plants play an important role in human life, primarily, as a source of food and medicine. Man is continuously faced with several lethal infectious diseases caused by pathogenic microorganisms [1]. In recent years, several pathogenic microorganisms have gained resistance to currently available synthetic antimicrobial agents and also caused many health problems [2]. Hence, there is an urgent need to discover an alternative new, broad spectrum, more active, and safer antimicrobial agent. Plant materials remain an important resource to combat serious diseases in the world. Especially, the plants from Pinaceae, Cupressaceae, Apiaceae, Burseraceae, Anacardiaceae, Palmaceae, Euphorbiaceae, Dracenaceae, and Fabaceae families are rich source for antimicrobial agents [3, 4]. Plants have an exceptional ability to synthesize de novo antimicrobial agents, in response to microbial attack for its protection [5]. Plant derived natural compounds (such as flavonoids, terpenoids, and steroids) have received considerable attention due to their diverse pharmacological properties including antibacterial and antifungal activities [6].
Antimicrobial components from plants which are mainly secondary metabolites act as inhibitors of bacterial growth, bacterial adherence, exopolysaccharide synthesis, DNA gyrase, cytoplasmic membrane function, and energy metabolism [7, 8]. Berberine, an isoquinoline alkaloid, which is present in roots and stem-bark of Berberis species, shows antimicrobial potential against bacteria, fungi, protozoa, and viruses [9]. Diterpene alkaloids, commonly isolated from the plants of the Ranunculaceae family, have antimicrobial properties [10]. Several phenolic compounds such as, caffeic acid, catechol, and pyrogallol are effective antimicrobial agents. The antibacterial activity of some monoterpenes, diterpenoids, sesquiterpenes, triterpenoids, and their derivatives isolated from plants was recently reported [11]. Nowadays, search for plants with antimicrobial activity has evolved [12]. Importance of plants in drug discovery is growing due to vast diversity of the secondary metabolites which possess varied biological activities and act as main source of molecule leading the discovery of new, effective, and safer drugs [13]. Recent attention has been paid to extraction and isolation of biologically active compounds from plant species which are used in herbal medicines [14]. Pharmacognostic investigations of plants or plant extracts were needed to ascertain their biological activities which lead to the discovery of novel drugs or templates for the development of new therapeutic agents [15].
Phyllanthus wightianus (Euphorbiaceae) is a monoecious glabrous shrub which grows up to 4.5 m high and is found in the hills (750 to 1000 m) of peninsular India, on the floor and border of shoals, low altitudes in sandveld, hot dry deciduous, mopane woodlands, along banks of seasonal streams, and rivers [16]. It exhibits various biological properties, such as antimicrobial [17–19], larvicidal [20, 21], analgesic [22], wound healing [23], and antioxidant properties [24]. On the basis of the above information, the present investigation was focused on antimicrobial properties of different solvent leaf extracts and GC-MS analysis of bioactive extract of P. wightianus Müll. Arg.
2. Materials and Methods
2.1. Plant Material
Fresh, matured, uninfected leaves of P. wightianus were collected from higher altitudes (900–1100 m) of Kolli Hills (latitude 10° 12′–11° 7′ N, longitude 76°–77° 17′ E), Namakkal district, Tamil Nadu, India. The plant material was authenticated by Botanical Survey of India (BSI) (reference number: BSI/SRC/5/23/2013-14/Tech/2081) Coimbatore, Tamil Nadu, India. The voucher specimen (specimen number: PU/BT/NDRL/2010/05) has been deposited in the Natural Drug Research Laboratory, Department of Biotechnology, Periyar University, Salem, Tamil Nadu, India.
2.2. Preparation of Extracts
Collected leaves were washed and shade-dried for three weeks and then powdered. The powdered plant material (500 g) was extracted in increasing polarity order (successively) with hexane, chloroform, acetone, ethyl acetate, and methanol in a Soxhlet apparatus for 72 hours. The extractives were filtered through Whatman number 1 filter paper and evaporated under vacuum at 40°C to yield crude extracts.
2.3. Used Microorganisms
Three gram positive bacteria, namely, B. subtilis (MTCC 441), S. pneumoniae (MTCC 655), S. epidermidis (MTCC 435), and eight gram negative bacterial strains, such as P. vulgaris (MTCC 426), P. aeruginosa (MTCC 741), K. pneumoniae (MTCC 109), S. typhimurium (MTCC 98), E. coli (MTCC 739), and S. flexneri (MTCC 1457), with two clinical isolates (P. vulgaris and S. marcescens) and 4 fungal pathogens (C. albicans, C. neoformans, M. racemosus, and A. niger) were used in this investigation. The fungal strains were obtained from clinical laboratories of Salem District, Tamil Nadu. Each test organism was prepared by inoculating a loop-full of mother culture in a 5 mL of broth (Muller-Hinton broth for bacteria and Sabourd Dextrose broth for fungal cultures) and incubated at appropriate temperature and time for bacterial pathogens (37°C for 16 hours) and fungal strains (room temperature (28°C) for 72 hours). The culture turbidity was adjusted to 0.5 McFarland equivalence (1.5 × 108 CUF) prior to use.
2.4. Agar Well Diffusion Method
The agar well diffusion method was employed to determine antibacterial activity of extracts as per the modified method of Natarajan et al. [19]. The standardized test cultures (50 μL) were swabbed on the per-molten Müeller Hinton Agar (MHA) for bacteria and Sabourd Dextrose Agar (SDA) for fungus using aseptic cotton swab. Six wells were made in the seeded plates using sterile cork borer (5 mm diameter). Then, each extract (50 μL = 50 μg) was separately introduced into wells and allowed to diffuse at room temperature. Equal volume of DMSO was served as negative control. About 25 μL of standard antibiotics like fluconazole (fungus) and ciprofloxacin (bacteria) was used as positive control (each 1 μg/μL). The bacterial and fungal plates were incubated at 37°C for 24 hours and at room temperature for 72 hours, respectively. After the incubation period, the zone of growth inhibition was measured (in mm).
2.5. Disc Diffusion Method
The disc diffusion test was performed by the method of NCCLS [25] with minor modifications. Test microbial suspension culture (50 μL) was spread on the MHA for bacteria and SDA for fungus by a sterile cotton swab. Sterile discs (5 mm diameter) were loaded with each extract (50 μL) and allowed to dry at room temperature. The dried discs were placed aseptically on the seeded plates. Standard antibiotic discs were used as positive control (gentamicin, vancomycin, and ampicillin for bacteria and fluconazole for fungus (10 mcg/disc)). The plates were incubated as the conditions mentioned in the well diffusion methods and the diameter (in mm) of clear zone of growth inhibition was recorded.
2.6. Minimum Inhibitory Concentration (MIC)
The MIC was determined by broth microdilution bioassay method using the modified method of Eloff et al. [26]. MIC was carried out on the basis of antimicrobial results, the extracts which exhibited considerable antimicrobial activity against tested organisms. 100 μL of different concentrations (1–1000 μg/mL) of extracts was introduced into 96-well microplates containing 200 μL of Muller-Hinton broth and 20 μL bacterial cultures were added to each well. The microplate was closed with lid and incubated for 24 h at 37°C. After incubation period, 40 μL of p-iodonitrotetrazolium violet (INT) (0.2 mg/mL) was added to the wells to serve as an indicator of bacterial growth and incubated at 37°C for 1 hour. The minimum inhibitory concentration (MIC) was taken as the lowest concentration of the extract that completely inhibited bacterial growth.
2.7. Minimum Bactericidal Concentration (MBC)
The MBC was determined as per method of Khan et al. [27]. MIC test dilutions (5 μl) which showed no color change was subcultured on freshly prepared Mueller Hinton Agar plates and incubated at 37°C for 24 h. The lowest concentration in which no bacterial growth occurred was taken as the Minimum Bactericidal Concentration.
2.8. GC-MS Analysis
GC-MS analysis of bioactive extract was carried out on GC Clarus 500 Perkin Elmer system comprising AOC-20i auto sampler. The spectrums of unknown components present in the bioactive extract were identified by compared with known components spectrum which stored in the NIST and WILEY libraries. The name, molecular weight and structure of the components present in the bioactive extract were ascertained. The GC-MS analysis was carried out at Sophisticated Analytical Instrument Facility (SAIF), Indian Institutes of Technology, Chennai, India.
2.9. Statistical Analysis
All determinations were done at least in triplicate and averaged. Values were expressed as mean ± standard deviations. Statistical analyses were conducted using SPPS software (16.0 Version). Analysis of variance (ANOVA) in a completely randomized design and Tukey's multiple range tests were used to compare any significant differences between samples. The confident limits used in this study were based on 95% (P < 0.05).
3. Results and Discussion
The color of extracts and extractive yield of the plant material are presented in Table 1. The results of antimicrobial activity of P. wightianus were given in Table 2. All the extracts of P. wightianus show broad spectrum antibacterial activity in the range between 6 and 29 mm. The results of agar well diffusion method show that methanolic extract has significant activity against S. pneumoniae (29 mm) followed by S. epidermidis (17 mm). The considerable amount of antibacterial activity was observed in acetone extract against S. pneumoniae (28 mm) followed by S. flexneri (12 mm). In disc diffusion method, methanol extract exhibits good antimicrobial activity and the maximum growth inhibition was observed in S. pneumoniae (18 mm) followed by S. epidermidis (17 mm). Acetone extract having well to moderate antimicrobial activity and maximum activity was detected in S. epidermidis (18 mm) followed by S. pneumoniae (14 mm). Most of the tested clinical fungal pathogenic strains exhibit no sensitivity on the tested extracts in both agar well and disc diffusion methods. However, high antifungal activity was recorded in methanol extract against C. neoformans (10 mm) followed by hexane extract against M. racemosus (10 mm) in well diffusion method (Table 2). The overall results highlight that methanol extract exhibits significant activity against most of the tested pathogens compared with other extracts.
Table 1.
Name of extract | Color | Yield (%) |
---|---|---|
Hexane | Yellowish green | 6.24 |
Chloroform | Dark green | 0.67 |
Acetone | Pale green | 1.33 |
Ethyl acetate | Pale brown | 2.49 |
Methanol | Brown | 4.61 |
Table 2.
S. number | Organisms | Method | Diameter of zone of inhibition (in mm)# | |||||
---|---|---|---|---|---|---|---|---|
Methanol | Acetone | Ethyl acetate | Chloroform | Hexane | Control* | |||
1 |
Bacillus subtilis
(MTCC 441) |
Well | 09.42 ± 0.52b | 07.96 ± 0.08b | 6.66 ± 0.58b | 00.00 ± 0.00a | 00.00 ± 0.00a | 29.74 ± 0.44c |
Disc | 08.71 ± 0.51c | 06.53 ± 0.50b | 00.00 ± 0.00a | 8.33 ± 0.58c | 08.33 ± 0.58c | 15.94 ± 0.10d | ||
| ||||||||
2 |
Escherichia coli
(MTCC 739) |
Well | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 27.56 ± 0.51b |
Disc | 07.71 ± 0.51b | 07.67 ± 0.58b | 07.62 ± 0.65b | 08.67 ± 0.58b | 08.70 ± 0.61b | 00.00 ± 0.00a | ||
| ||||||||
3 |
Klebsiella pneumoniae
(MTCC 109) |
Well | 09.52 ± 0.50b | 10.72 ± 0.63c | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 29.54 ± 0.51d |
Disc | 09.60 ± 0.36c | 08.00 ± 0.08b | 09.83 ± 0.48c | 08.67 ± 0.58b,c | 08.72 ± 0.63b,c | 00.00 ± 0.00a | ||
| ||||||||
4 |
Proteus vulgaris
(MTCC 426) |
Well | 09.56 ± 0.45b | 10.96 ± 0.08c | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 24.65 ± 0.36d |
Disc | 09.82 ± 0.32d | 08.74 ± 0.65c,d | 07.67 ± 0.58b,c | 07.05 ± 0.93b | 07.51 ± 0.50b,c | 00.00 ± 0.00a | ||
| ||||||||
5 |
Pseudomonas aeruginosa
(MTCC 741) |
Well | 12.75 ± 0.66b | 11.65 ± 0.56b | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 22.67 ± 0.58c |
Disc | 11.75 ± 0.44d | 09.83 ± 0.30c | 6.88 ± 0.43b | 00.00 ± 0.00a | 09.64 ± 0.40c | 00.00 ± 0.00a | ||
| ||||||||
6 |
Salmonella typhimurium
(MTCC 98) |
Well | 09.59 ± 0.66c | 11.77 ± 0.68d | 08.47 ± 0.50b | 00.00 ± 0.00a | 08.47 ± 0.50b | 29.96 ± 0.08e |
Disc | 09.67 ± 0.58c | 08.70 ± 0.61b,c | 08.59 ± 0.71b,c | 07.27 ± 1.10b | 07.87 ± 0.23b | 00.00 ± 0.00a | ||
| ||||||||
7 |
Shigella flexneri
(MTCC 1457) |
Well | 13.80 ± 0.35d | 12.77 ± 0.68d | 07.81 ± 0.33c | 06.51 ± 0.50b | 00.00 ± 0.00a | 15.67 ± 0.58e |
Disc | 13.84 ± 0.28d | 11.77 ± 0.68c | 07.82 ± 0.45b | 07.78 ± 0.47b | 08.85 ± 0.25b | 00.00 ± 0.00a | ||
| ||||||||
8 |
Streptococcus pneumoniae
(MTCC 655) |
Well | 29.71 ± 0.51c | 28.55 ± 0.51c | 10.73 ± 0.64b | 08.67 ± 0.58a | 08.00 ± 1.00a | 34.67 ± 0.58d |
Disc | 18.85 ± 0.25d | 14.54 ± 0.50c | 08.13 ± 0.13a | 08.67 ± 0.58a,b | 09.50 ± 0.50b | 19.52 ± 0.50d | ||
| ||||||||
9 |
Staphylococcus epidermidis
(MTCC 435) |
Well | 17.83 ± 0.29b | 10.73 ± 0.64a | 17.00 ± 1.00b | 10.67 ± 0.58a | 11.84 ± 0.77a | 29.83 ± 0.29c |
Disc | 17.93 ± 0.12b | 18.33 ± 0.58b | 07.67 ± 0.58a | 07.87 ± 0.23a | 08.67 ± 0.58a | 17.80 ± 0.72b | ||
| ||||||||
10 | Proteus vulgaris | Well | 00.00 ± 0.00a | 07.77 ± 0.39b | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 21.84 ± 0.27c |
Disc | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 10.75 ± 0.67b | ||
| ||||||||
11 | Serratia marcescens | Well | 00.00 ± 0.00a | 00.00 ± 0.00a | 08.33 ± 0.32b | 00.00 ± 0.00a | 00.00 ± 0.00a | 24.67 ± 0.58c |
Disc | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 12.42 ± 1.01b | ||
| ||||||||
Fungal cultures | ||||||||
1 | C. albicans | Well | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.000 ± 0.0 | 00.00 ± 0.00a |
Disc | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | ||
| ||||||||
2 | C. neoformans | Well | 10.41 ± 0.52d | 07.56 ± 0.39c | 09.78 ± 0.39d | 06.51 ± 0.50b | 00.00 ± 0.00a | 00.00 ± 0.00a |
Disc | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 00.00 ± 0.00a | 27.29 ± 10.3b | ||
| ||||||||
3 | M. racemosus | Well | 07.67 ± 0.58b | 09.07 ± 0.40b,c | 09.67 ± 0.58b,c | 09.73 ± 0.46b,c | 10.67 ± 0.58c | 00.00 ± 0.00a |
Disc | 00.00 ± 0.00a | 00.00 ± 0.00a | 07.93 ± 0.12c | 06.80 ± 0.35b | 09.07 ± 0.12c | 00.00 ± 0.00a | ||
| ||||||||
4 | A. niger | Well | 09.67 ± 0.58d | 07.93 ± 0.12b,c | 09.77 ± 0.40c,d | 07.77 ± 0.25b | 09.57 ± 0.51d | 00.00 ± 0.00a |
Disc | 07.80 ± 0.35b,c | 06.67 ± 0.58b | 07.67 ± 0.58b,c | 00.00 ± 0.00a | 08.67 ± 0.58d | 00.00 ± 0.00a |
*Standard antibiotics (in well diffusion: ciprofloxacin (1 mg mL−1) for bacteria and fluconazole (1 mg mL−1) for fungus; in disc diffusion: gentamicin, vancomycin, and ampicillin (10 mcg/disc) for bacteria and fluconazole (10 mcg/disc) for fungus). #The values are mean of triplicates with standard deviations (mean ± S.D; n = 3). Different superscript letters (a–e) in rows indicate significant differences (at P < 0.05) when subject to Tukey's multiple comparison test.
The MIC and MBC results (Tables 3 and 4) indicate that the crude extracts of P. wightianus inhibited the growth of selected bacterial species. The lowest MIC and MBC value were detected in methanolic extract against S. pneumoniae (15.62 μg/mL) and S. epidermidis (31.25 μg/mL). The rest of extracts showed moderate to high MIC and MBC values (500–>1000a μg/mL) against most of the tested bacterial pathogens. Plant extracts are considered as having a good inhibitory activity, if they present MICs ≤ 100 μg/mL, a moderate inhibitory activity, if they present MICs ranging from 100 to 500 μg/mL, a weak inhibitory activity, if they present MICs ranging from 500 to 1000 μg/mL, and no inhibitory activity, if they present MICs > 1000a μg/mL [28, 29]. While considering these reports, the MIC and MBC values recorded from antibacterial activity of present investigation might be good to moderate.
Table 3.
Organisms | Methanol | Acetone | Ethyl acetate | Chloroform | Hexane | Ciprofloxacin |
---|---|---|---|---|---|---|
Bacillus subtilis
(MTCC 441) |
>1000a | >1000a | >1000a | >1000a | >1000a | 3.9b |
| ||||||
Escherichia coli
(MTCC 739) |
>1000a | >1000a | >1000a | >1000a | >1000a | 15.62b |
| ||||||
Klebsiella pneumoniae
(MTCC 109) |
500b | >1000a | >1000a | >1000a | >1000a | 7.81c |
| ||||||
Proteus vulgaris
(MTCC 426) |
>1000a | >1000a | >1000a | >1000a | >1000a | 15.62b |
| ||||||
Pseudomonas aeruginosa
(MTCC 741) |
250c | 250c | 500b | >1000a | >1000a | 31.25d |
| ||||||
Salmonella typhimurium
(MTCC 98) |
500 | >1000a | >1000a | >1000a | >1000a | 15.62 |
| ||||||
Shigella flexneri
(MTCC 1457) |
125d | 250c | 500b | >1000a | >1000a | 31.25e |
| ||||||
Streptococcus pneumoniae
(MTCC 655) |
15.62d | 31.25c | 250b | >1000a | >1000a | 3.9e |
| ||||||
Staphylococcus epidermidis
(MTCC 435) |
31.25d | 62.5c | 500b | >1000a | >1000a | 3.9c |
The values are mean of triplicates. Different superscript letters (a–e) in rows indicate significant differences (at P < 0.05) when subject to Tukey's multiple comparison test.
Table 4.
Organisms | Methanol | Acetone | Ethyl acetate | Chloroform | Hexane | Ciprofloxacin |
---|---|---|---|---|---|---|
Bacillus subtilis
(MTCC 441) |
>1000a | >1000a | >1000a | >1000a | >1000a | 15.62b |
| ||||||
Escherichia coli
(MTCC 739) |
>1000a | >1000a | >1000a | >1000a | >1000a | 31.25b |
| ||||||
Klebsiella pneumoniae
(MTCC 109) |
>1000a | >1000a | >1000a | >1000a | >1000a | 15.62b |
| ||||||
Proteus vulgaris
(MTCC 426) |
>1000a | >1000a | >1000a | >1000a | >1000a | 31.25b |
| ||||||
Pseudomonas aeruginosa
(MTCC 741) |
500b | 500b | 500b | >1000a | >1000a | 31.25c |
| ||||||
Salmonella typhimurium
(MTCC 98) |
500b | >1000a | >1000a | >1000a | >1000a | 31.25c |
| ||||||
Shigella flexneri
(MTCC 1457) |
250c | 250c | 500b | >1000a | >1000a | 62.5d |
| ||||||
Streptococcus pneumoniae
(MTCC 655) |
15.62d | 62.5c | 500b | >1000a | >1000a | 3.9e |
| ||||||
Staphylococcus epidermidis
(MTCC 435) |
31.25c | 125b | 1000a | >1000a | >1000a | 3.9d |
The values are mean of triplicates. Different superscript letters (a–e) in rows indicate significant differences (at P < 0.05) when subject to Tukey's multiple comparison test.
The results highlights that significant antibacterial activity was observed in methanol extract against S. flexneri, S. pneumoniae, and S. epidermidis. Similar observations were made with P. wightianus methanolic extract [17]. Our previous findings, report that acetone extract expresses significant activity against most of the clinical bacterial pathogens compared to methanol extract [19]. Whereas, the present results show MTCC bacterial strains to be more sensitive to the methanol extract than acetone extract of P. wightianus. This difference in observation may be due to the high concentration (5 mg/well/disc) of extracts being used in the earlier study, whereas, in the present findings, low concentrations of extracts did not inhibit bacterial growth.
Studies have shown that methanolic extracts of many Phyllanthus species, such as P. acidus [30], P. muellerianus [31], P. amarus, P. maderaspatensis [32], P. debilis [33], P. amarus, P. emblica [34], and P. niruri [35], harbor promising antimicrobial activity which strengthens the present findings. Several reports stated that methanol is potent solvent for extracting variety of important phytoconstituents, like alkaloids, phenols, tannins, fatty acids, and flavonoids, which harbor antimicrobial potential which support the findings of present investigation [36, 37].
GC-MS analysis shows the presence of 29 compounds which were identified based on their retention time (RT), molecular formula, molecular weight (MW), and concentration (%) (Figure 1 and Table 5). Methnolic extract of P. wightianus has 9,12-octadecadienoic acid (with the peak area 22.82% and retention time 23.970) and N-hexadecanoic acid (with the peak area 21.55% and retention time 21.796) acting as major components. A variety of compounds, such as aliphatic ether, aliphatic carboxylic acid, aliphatic ester, alkene, and phenolic compounds were identified. Some of the compounds were present only in low quantities (ranging from 0.6 to 4%).
Table 5.
Peak | R. time | Peak area (%) | Molecular formula | Molecular weight | Compound name |
---|---|---|---|---|---|
1 | 4.726 | 0.94 | C6H12O2 | 116 | 2-Pentanone, 4-hydroxy-4-methyl-3 2-hydroxy-2-methyl-4-pentanone 2- |
| |||||
2 | 9.358 | 0.28 | C6H6O3 | 126 | Levoglucosenone 6,8-ioxabicyclooct-2-en-4-one |
| |||||
3 | 10.907 | 0.67 | C8H8O | 120 | 4-Vinylphenol |
| |||||
4 | 11.198 | 0.26 | C8H18O2 | 174 | T-Butyldimethylsilyl acetate |
| |||||
5 | 12.387 | 0.08 | C13H16O2 | 204 | 1-(4-Methoxyphenyl)-5-hexen-1-one |
| |||||
6 | 13.436 | 1.60 | C6H6O3 | 126 | 1,2,3-Benzenetriol (pyrogallol) |
| |||||
7 | 15.093 | 6.07 | C15H24O2 | 236 | Butanoic acid, 3-methyl-, 3,7 dimethyl-2,4,6-octatrienyl ester |
| |||||
8 | 15.241 | 3.56 | C15H20Br2O2 | 390 | 3,8-Dioxabicyclononane, 6-bromo-4-(1-bromopropyl)-2-[2-penten-4-ynyl] |
| |||||
9 | 15.525 | 1.04 | C14H22O | 206 | Phenol, 2,4-bis(1,1-dimethylethyl)-2,4-ditert-butylphenol 1-hydroxy-2, 4-di-tert-butylbenze |
| |||||
10 | 16.037 | 2.46 | C11H16O2 | 180 | 2-Benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl- (2,6,6-trimethyl-2-hydroxycyclohexylidene)acetic acid lactone 4,5 |
| |||||
11 | 16.586 | 0.55 | C12H14O4 | 222 | 1,2-Benzenedicarboxylic acid, diethyl ester phthalic acid |
| |||||
12 | 17.658 | 0.77 | C21H32O3 | 332 | β-Dodecahydro |
| |||||
13 | 19.062 | 0.71 | C11H16O3 | 196 | 2(4h)-Benzofuranone, 5,6,7,7a-tetrahydro-6-hydroxy-4,4,7a-trimethyl-, (6s-cis)-(—)-loliolide |
| |||||
14 | 19.716 | 3.03 | C13H20O2 | 208 | Pluchidiol |
| |||||
15 | 20.264 | 10.65 | C20H38 | 278 | 2,6,10-Trimethyl,14-ethylene-14-pentadecne |
| |||||
16 | 20.347 | 1.19 | C18H36O | 268 | 2-Pentadecanone, 6,10,14-trimethyl- hexahydrofarnesyl acetone 6,10,14 |
| |||||
17 | 20.591 | 3.16 | C20H40 | 296 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol (2e)-3,7,11,15-tetramethyl |
| |||||
18 | 20.831 | 5.85 | C20H40 | 296 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol (2e)-3,7,11,15-tetramethyl |
| |||||
19 | 20.925 | 0.36 | C24H34O2 | 446 | Butanal |
| |||||
20 | 21.674 | 0.58 | C10H20 | 156 | 6-Octen-1-ol, 3,7-dimethyl- |
| |||||
21 | 21.796 | 21.55 | C16H32O2 | 256 | N-Hexadecanoic acid, palmitic acid, pentadecanecarboxylic acid |
| |||||
22 | 23.300 | 0.53 | C18H38O | 270 | Bis-(3,5,5-trimethylhexyl) ether |
| |||||
23 | 23.808 | 0.40 | C20H38 | 278 | 2,6,10-Trimethyl,14-ethylene-14-pentadecne neophytadiene |
| |||||
24 | 23.881 | 3.81 | C11H22O2 | 186 | Nonanoic acid, 7-methyl ester methyl 7-methylnonanoate |
| |||||
25 | 23.970 | 22.82 | C18H32O2 | 280 | 9,12-Octadecadienoic acid-linoleic acid grape seed oil linoleic linole |
| |||||
26 | 24.199 | 5.93 | C18H30O2 | 278 | 9,12,15-Octadecatrienoic acid, linolenic acids alpha-linolenic acid |
| |||||
27 | 24.308 | 0.68 | C18H36O2 | 284 | Octadecanoic acid (stearic acid) |
| |||||
28 | 26.055 | 0.46 | C8H14O | 126 | (3z)-6-methyl-3,6-heptadien-1-ol |
N-Hexadecanoic acid and 9,12-octadecadienoic acid are common secondary metabolites present in several plants [38–43] and are reported as having many biological properties, like antimicrobial, anti-inflammatory, hypocholesterolemic, cancer preventive, hepatoprotective, and antioxidant [44, 45]. 9,12-Octadecadienoic acid was also stated as a model compound of unsaturated fatty acids, which selectively inhibits FabI enzyme in S. aureus and E. coli, catalyzing the final and rate-limiting step of the chain elongation process of the type II fatty acid synthesis (FAS-II) in bacteria [46].
Several fatty acids and phenolic compounds were identified in GC-MS analysis of methanol extract which may be the responsible for the antimicrobial activity. The mechanisms of antimicrobial action of fatty acids are nonspecific modes of action [47]. However, antimicrobial effects of fatty acids were observed to form mostly either by a complete inhibition of oxygen uptake or stimulating uptake of amino acids into the cells, which occurs in a dose dependent manner [48]. Fatty acids intercalate in the phospholipid bilayer of microbes due to their lipophilicity, which increases the permeability of the cell membrane, dissipation of the proton-motive force, and leakage of inorganic ions, leading to cell death [49, 50].
Studies have shown that phenolic compounds have bactericidal action by interfering with bacterial cell adhesins, enzymes, cell envelope, and transport proteins [51]. They also increase the free radical concentration within the bacterial protoplasm and irreversibly complex with nucleophilic amino acids in microbial proteins determining loss of their function [52]. As a result, this causes bacterial cell lysis [53]. The antibacterial activity of methanol extract is not only caused by their major compounds, but it could be due to a synergism among their other components present in it. Hence, the presence of these components in higher quantity in methanol extract of P. wightianus may be responsible for better bioactivity.
4. Conclusions
The findings of present investigation show that agar well diffusion method is ideal for determining the antimicrobial activity of P. wightianus extracts. Methanolic extract of P. wightianus contributed significant activity against most of the tested bacterial pathogens with least MIC and MBC values. Hence, methanol is the best solvent system for extracting the bioactive principles from leaves of P. wightianus which possesses promising antimicrobial principles which may be used in the treatment of infectious diseases caused by pathogenic microbes. The antimicrobial principles from the bioactive extracts may need further purifications to have its synthetic analogues which will be carried out in the future.
Acknowledgments
The authors are gratefully thankful to the University Grants Commission (UGC), New Delhi (reference no. 37-296/2009 (SR)) for providing financial assistance and the Department of Biotechnology, Periyar University, Salem, for the necessary facilities.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
References
- 1.Das S, Sarkar A, Seth A, Gupta N, Agrawal RC. Evaluation of in-vitro antibacterial potential of ripe fruits of Aegle marmelos . International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4(3):179–181. [Google Scholar]
- 2.Doudach L, Meddah B, Alnamer R, Chibani F, Cherrah Y. In vitro antibacterial activity of the methanolic and aqueous extracts of Anacyclus pyrethrum used in Moroccan traditional medicine. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4(3):402–405. [Google Scholar]
- 3.Termentzi A, Fokialakis N, Skaltsounis AL. Natural resins and bioactive natural products thereof as potential anitimicrobial agents. Current Pharmaceutical Design. 2011;17(13):1267–1290. doi: 10.2174/138161211795703807. [DOI] [PubMed] [Google Scholar]
- 4.Paraschos S, Mitakou S, Skaltsounis AL. Chios gum mastic: a review of its biological activities. Current Medicinal Chemistry. 2012;19(14):2292–2302. doi: 10.2174/092986712800229014. [DOI] [PubMed] [Google Scholar]
- 5.Gibbons S. Plants as a source of bacterial resistance modulators and anti-infective agents. Phytochemistry Reviews. 2005;4(1):63–78. [Google Scholar]
- 6.Singha PK, Roy S, Dey S. Antimicrobial activity of Andrographis paniculata . Fitoterapia. 2003;74(7-8):692–694. doi: 10.1016/s0367-326x(03)00159-x. [DOI] [PubMed] [Google Scholar]
- 7.Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils—a review. Food and Chemical Toxicology. 2008;46(2):446–475. doi: 10.1016/j.fct.2007.09.106. [DOI] [PubMed] [Google Scholar]
- 8.Jeon J-G, Rosalen PL, Falsetta ML, Koo H. Natural products in caries research: current (limited) knowledge, challenges and future perspective. Caries Research. 2011;45(3):243–263. doi: 10.1159/000327250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kim SH, Lee SJ, Lee JH, Sun WS, Kim JH. Antimicrobial activity of 9-O-acyl- and 9-O-alkylberberrubine derivatives. Planta Medica. 2002;68(3):277–281. doi: 10.1055/s-2002-23128. [DOI] [PubMed] [Google Scholar]
- 10.Attar-ur-Rahman, Choudhary MI. Diterpenoid and steroidal alkaloids. Natural Product Reports. 1995;12(4):361–379. doi: 10.1039/np9951200361. [DOI] [PubMed] [Google Scholar]
- 11.Kurek A, Grudniak AM, Kraczkiewicz-Dowjat A, Wolska KI. New antibacterial therapeutics and strategies. Polish Journal of Microbiology. 2011;60(1):3–12. [PubMed] [Google Scholar]
- 12.Vermani K, Garg S. Herbal medicines for sexually transmitted diseases and AIDS. Journal of Ethnopharmacology. 2002;80(1):49–66. doi: 10.1016/s0378-8741(02)00009-0. [DOI] [PubMed] [Google Scholar]
- 13.Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. Journal of Ethnopharmacology. 1998;62(2):183–193. doi: 10.1016/s0378-8741(98)00055-5. [DOI] [PubMed] [Google Scholar]
- 14.Essawi T, Srour M. Screening of some Palestinian medicinal plants for antibacterial activity. Journal of Ethnopharmacology. 2000;70(3):343–349. doi: 10.1016/s0378-8741(99)00187-7. [DOI] [PubMed] [Google Scholar]
- 15.Natarajan D, Shivakumar MS, Srinivasan R. Antibacterial activity of leaf extracts of Biophytum sensitivum (L.) DC. Journal of Pharmaceutical Sciences and Research. 2010;2(11):717–720. [Google Scholar]
- 16.Radcliffe-Smith A. Euphorbiaceae. In: Pope GV, editor. Flora Zambesiaca. 9 (4) Kew, UK: Royal Botanic Gardens; 1999. p. p. 334. [Google Scholar]
- 17.Mohanasundari C, Natarajan D, Srinivasan K, Anbuganapathi G, Gowrishankar J, Perumal G. Antibacterial efficacy of leaf extracts of Phyllanthus wightianus Müll. Arg. Journal of Phytological Research. 2005;18(2):171–173. [Google Scholar]
- 18.Sengottuvel R, Srinivasan K, Mohanasundari C, Natarajan D, Perumal G. Screening of antimicrobial properties of leaf extracts of Smilax zeylanica and Phyllanthus wightianus . Advances in Plant Sciences. 2007;20(1):273–275. [Google Scholar]
- 19.Natarajan D, Srinivasan R, Shivakumar MS. Phyllanthus wightianus Müll. Arg.: a potential source for antibacterial and phytochemical analysis. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4(5):241–245. [Google Scholar]
- 20.Srinivasan R, Shivakumar MS, Natarajan D. Larvicidal efficacy of Phyllanthus wightianus Müll. Arg. on Aedes aegypti . In: Tyagi BK, editor. Proceedings of the 5th Conference of Medical Arthropodology; 2012; Madurai, India. pp. 37–43. [Google Scholar]
- 21.Shivakumar MS, Srinivasan R, Natarajan D. Larvicidal potential of some Indian medicinal plant extracts against Aedes aegypti (L.) Asian Journal of Pharmaceutical and Clinical Research. 2013;6(3):77–80. [Google Scholar]
- 22.Valarmathi R, Scnthamarai R, Akilandeswari S. Analgesic and antimicrobial activity of the dried root extracts of Reidia floribunda Wight. Hamdard Medicus. 2009;52(2):18–23. [Google Scholar]
- 23.Priya OS. Wound healing activity of Phyllanthus wightianus . Proceedings of the International Herbal Conference; 2009; Bangalore, India. [Google Scholar]
- 24.Priya OS, Viswanathan MBG, Balakrishna K, Venkatesan M. Chemical constituents and in vitro antioxidant activity of Phyllanthus wightianus . Natural Product Research. 2011;25(10):949–958. doi: 10.1080/14786419.2010.517203. [DOI] [PubMed] [Google Scholar]
- 25.National Committee for Clinical Laboratory Standards (NCCLS) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 7th edition. M7-A7. Wayne, Pa, USA.: National Committee on Clinical Laboratory Standards (NCCLS); 2006. [Google Scholar]
- 26.Eloff JN, Katerere DR, McGaw LJ. The biological activity and chemistry of the southern African Combretaceae. Journal of Ethnopharmacology. 2008;119(3):686–699. doi: 10.1016/j.jep.2008.07.051. [DOI] [PubMed] [Google Scholar]
- 27.Khan R, Islam B, Akram M, et al. Antimicrobial activity of five herbal extracts against Multi Drug Resistant (MDR) strains of bacteria and fungus of clinical origin. Molecules. 2009;14(2):586–597. doi: 10.3390/molecules14020586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Tanaka JCA, da Silva CC, Filho BPD, Nakamura CV, de Carvalho JE, Foglio MA. Chemical constituents of Luehea divaricata Mart. (Tiliaceae) Quimica Nova. 2005;28(5):834–837. [Google Scholar]
- 29.Dall’Agnol R, Ferraz A, Bernardi AP, et al. Antimicrobial activity of some Hypericum species. Phytomedicine. 2003;10(6):511–516. doi: 10.1078/094471103322331476. [DOI] [PubMed] [Google Scholar]
- 30.Jagessar RC, Mars A, Gomes G. Selective Antimicrobial properties of Phyllanthus acidus leaf extract against Candida albicans, Escherichia coli and Staphylococcus aureus using Stokes Disc diffusion, Well diffusion, Streak plate and a dilution method. Natural Science. 2008;6(2):24–38. [Google Scholar]
- 31.Onocha PA, Opegbemi AO, Kadri AO, Ajayi KM, Okorie DA. Euphorbiaceae plants 1: Phyllanthus amarus and Phyllanthus muellerianus leaf extracts. Nigerian Journal of Natural Product of Medicine. 2003;7:9–12. [Google Scholar]
- 32.Ashokkumar R, Ramaswamy M. Comparative study on the antimicrobial activity of leaf extracts of four selected Indian medicinal plants against Pseudomonas aeruginosa, Pseudomonas fluorescens, Penicillium chrysogenum and Penicillium restrictum . Journal of Chemical Biology Physical Science. 2013;3(2):1279–1282. [Google Scholar]
- 33.Chandrashekar KS, Satyanarayana, Prasanna KS. Antimicrobial activity of Phyllanthus debilis . International Research Journal of Pharmacy. 2011;2(6):75–76. [Google Scholar]
- 34.de Britto J, Gracelin DHS, Sebastian SR. Antibacterial activity of a few medicinal plants against Xanthomonas campestris and Aeromonas hydrophila . Journal of Biopesticides. 2011;4(1):57–60. [Google Scholar]
- 35.Mathur M, Sharma R, Sharma J, Pareek R, Kamal R. Phytochemical screening and antimicrobial activity of Phyllanthus niruri Linn. Applied Botany. 2012;46:8487–8489. [Google Scholar]
- 36.Sivaraj R, Balakrishnan A, Thenmozhi M, Venckatesh R. Preliminary phytochemical analysis of Aegle marmelos, Ruta graveolens, Opuntia dellini, Euphorbia royleana and Euphorbia antiquoru . International Journal of Pharmaceutical Science Research. 2011;2(1):146–150. [Google Scholar]
- 37.Proestos C, Chorianopoulos N, Nychas E, Komaitis M. RP-HPLC analysis of the phenolic compounds of plant extracts. Investigation of their antioxidant capacity and antimicrobial activity. Journal of Agricultural and Food Chemistry. 2005;53(4):1190–1195. doi: 10.1021/jf040083t. [DOI] [PubMed] [Google Scholar]
- 38.Lee J-C, Kim H-R, Kim J, Jang Y-S. Antioxidant property of an ethanol extract of the stem of Opuntia ficus-indica var. Saboten . Journal of Agricultural and Food Chemistry. 2002;50(22):6490–6496. doi: 10.1021/jf020388c. [DOI] [PubMed] [Google Scholar]
- 39.Sermakkani M, Thangapandian V. GC-MS analysis of Cassia italica leaf methanol extract. Asian Journal of Pharmaceutical Clinical Research. 2012;5(2):90–94. [Google Scholar]
- 40.Al-Shammari AL, Hassan HBW, Al-Youssef AH. Chemical composition and antimicrobial activity of the essential oil and lipid content of Carduus pycnocephalus L. growing in Saudi Arabia. Journal of Chemical and Pharmaceutical Research. 2012;4(2):1281–1287. [Google Scholar]
- 41.Albishri HM, Almaghrabi OA, Moussa TAA. Characterization and chemical composition of fatty acids content of watermelon and muskmelon cultivars in Saudi Arabia using gas chromatography/mass spectroscopy. Pharmacongnosy Magazine. 2013;9(33):58–66. doi: 10.4103/0973-1296.108142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Preethi RV, Devanathan V, Loganathan M. Antimicrobial and antioxidant efficacy of some medicinal plants against food borne pathogens. Advananced Biological Research. 2010;4(2):122–125. [Google Scholar]
- 43.Rajeswari G, Murugan M, Mohan VR. GC-MS analysis of bioactive components of Hugonia mystax L. (Linaceae) Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2013;3(4):301–308. [Google Scholar]
- 44.Gunstone FD, Harwood JL, Padley FB. The Lipid Handbook. 2nd edition. London, UK: Chapman & Hall; 1994. [Google Scholar]
- 45.Maruthupandian A, Mohan VR. GC-MS analysis of some bioactive constituents of Pterocarpus marsupium Roxb. International Journal of Chemical Technology Research. 2011;3(3):1652–1657. [Google Scholar]
- 46.Zheng CJ, Yoo J-S, Lee T-G, Cho H-Y, Kim Y-H, Kim W-G. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Letters. 2005;579(23):5157–5162. doi: 10.1016/j.febslet.2005.08.028. [DOI] [PubMed] [Google Scholar]
- 47.Davidson PM, Sofos JN, Branen AL. Antimicrobials in Foods. 3rd edition. Boca Raton, Fla, USA: CRC Press; 2005. [Google Scholar]
- 48.Orhan I, Özçelik B, Şener B. Evaluation of antibacterial, antifungal, antiviral, and antioxidant potentials of some edible oils and their fatty acid profiles. Turkish Journal of Biology. 2011;35(2):251–258. [Google Scholar]
- 49.Souza EL, Oliveira CEV, Stamford TLM, Conceicao ML, Neto NJG. Influence of carvacrol and thymol on the physiological attributes, enterotoxin production and surface characteristics of Staphylococcus aureusstrains isolated from foods. Brazilian Journal of Microbiology. 2013;44(1):29–35. doi: 10.1590/S1517-83822013005000001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Lambert RJW, Skandamis PN, Coote PJ, Nychas GJE. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. Journal of Applied Microbiology. 2001;91(3):453–462. doi: 10.1046/j.1365-2672.2001.01428.x. [DOI] [PubMed] [Google Scholar]
- 51.Cazarolli LH, Zanatta L, Alberton EH, et al. Flavonoids: prospective drug candidates. Mini-Reviews in Medicinal Chemistry. 2008;8(13):1429–1440. doi: 10.2174/138955708786369564. [DOI] [PubMed] [Google Scholar]
- 52.Saleem M, Nazir M, Ali MS, et al. Antimicrobial natural products: an update on future antibiotic drug candidates. Natural Product Reports. 2010;27(2):238–254. doi: 10.1039/b916096e. [DOI] [PubMed] [Google Scholar]
- 53.Engels C, Schieber A, Gänzle MG. Inhibitory spectra and modes of antimicrobial action of gallotannins from mango kernels (Mangifera indica L.) Applied and Environmental Microbiology. 2011;77(7):2215–2223. doi: 10.1128/AEM.02521-10. [DOI] [PMC free article] [PubMed] [Google Scholar]